ArticleJournal of thrombosis and thrombolysis2020

Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center.

Sweta Meet Patel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.